Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults
ConditionSleep
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversidad de Granada
About this trial
This randomized, triple-blind, placebo-controlled clinical trial aims to evaluate the effects of daily saffron extract supplementation (30 mg/day) for six weeks on objective and subjective sleep quality in middle-aged adults with mild-to-moderate sleep disturbances. Secondary outcomes include heart rate variability, cognitive processing speed, emotional state, perceived health status, and biochemical stress markers.
Eligibility criteria
Qualifiers
Age 18-65 years
Mild-to-moderate sleep disturbances
BMI between 18 and 35 kg/m²
Not receiving active pharmacological or psychological treatment for sleep disorders
Disqualifiers
Severe neurological, psychiatric, or cardiovascular disorders
Diagnosed with obstructive sleep apnea, treated with CPAP
Night shift workers
Use of medications or supplements affecting sleep
Trial design
Treatments tested in this trial
- Saffron Extract
- Dietary Supplement: Placebo
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov